dutasteride
UkraineDrugs containing this active substance
-
The drug is prescribed for the treatment of symptoms of moderate to severe benign prostatic hyperplasia. It also helps to reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, soft gelatin
Active substance Dosage dutasteride 0.5 mg ATC: G04CB02
Manufacturer: Delpharm Poznan S.A.
-
The drug is used to treat moderate to severe symptoms of benign prostatic hyperplasia. It helps reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, hard
Active substance Dosage dutasteride 0.5 mg tamsulosin 0.4 mg ATC: G04CA52
Manufacturer: Catalent Germany Schoorl GmbH
-
The drug is prescribed for the treatment of moderate to severe symptoms of benign prostatic hyperplasia, as well as to reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, hard
Active substance Dosage dutasteride 0.5 mg tamsulosin 0.4 mg ATC: G04CA52
Manufacturer: STADA Arzneimittel AG (batch release)
-
The drug is used to treat symptoms of moderate to severe benign prostatic hyperplasia. It also helps reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, soft gelatin
Active substance Dosage dutasteride 0.5 mg ATC: G04CB02
Manufacturer: JSC "Kyiv Vitamin Plant" (manufacturing of bulk products "GAP SA", Greece)
-
The drug is intended for the treatment of moderate to severe symptoms of benign prostatic hyperplasia. It helps reduce the risk of acute urinary retention and lowers the likelihood of the need for surgical intervention.
Form: capsules, hard
Active substance Dosage dutasteride 0.5 mg tamsulosin 0.4 mg ATC: G04CA52
-
The drug is used to treat moderate to severe symptoms of benign prostatic hyperplasia. It helps facilitate urination, reduces the risk of acute urinary retention, and decreases the likelihood of requiring surgical intervention.
Form: capsules, hard
Active substance Dosage dutasteride 0.5 mg tamsulosin 0.4 mg ATC: G04CA52
-
The drug is intended for the treatment of moderate to severe symptoms of benign prostatic hyperplasia. It helps reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, hard
Active substance Dosage dutasteride 0.5 mg tamsulosin 0.4 mg ATC: G04CA52
Manufacturer: SAG MANUFACTURING, S.L.U. (manufacturing, primary and secondary packaging, quality control and batch release)
-
The drug is used to treat symptoms of moderate to severe benign prostatic hyperplasia. It also helps to reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, soft gelatin
Active substance Dosage dutasteride 0.5 mg ATC: G04CB02
Manufacturer: Olive Pharmaceuticals Limited
-
The drug is prescribed for the treatment of moderate to severe symptoms of benign prostatic hyperplasia. It helps reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, hard
Active substance Dosage dutasteride 0.5 mg tamsulosin 0.4 mg ATC: G04CA52
-
The drug is used to treat symptoms of moderate to severe benign prostatic hyperplasia. It also helps reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, soft gelatin
Active substance Dosage dutasteride 0.5 mg ATC: G04CB02
Manufacturer: Galenicum Health S.L.U. (batch release, physico-chemical control of batch)
-
The drug is used to treat symptoms of moderate to severe benign prostatic hyperplasia. It also helps reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, soft gelatin
Active substance Dosage dutasteride 0.5 mg ATC: G04CB02
-
The drug is used for the treatment of moderate to severe benign prostatic hyperplasia. It helps reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, soft gelatin
Active substance Dosage dutasteride 0.5 mg ATC: G04CB02
Manufacturer: ALKALOID AD Skopje (manufacturer, responsible for batch release)
-
The drug is intended for the treatment of moderate to severe symptoms of benign prostatic hyperplasia. It helps reduce the risk of acute urinary retention and decreases the likelihood of the need for surgical intervention.
Form: capsules, hard
Active substance Dosage dutasteride 0.5 mg tamsulosin 0.4 mg ATC: G04CA52
-
The drug is used to treat symptoms of moderate to severe benign prostatic hyperplasia. It also helps reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, soft gelatin
Active substance Dosage dutasteride 0.5 mg ATC: G04CB02
Manufacturer: Oliv Helsker
-
The drug is used to treat symptoms of moderate to severe benign prostatic hyperplasia. It also helps reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, soft gelatin
Active substance Dosage dutasteride 0.5 mg ATC: G04CB02
Manufacturer: Oliv Helsker
-
The drug is used to treat symptoms of moderate to severe benign prostatic hyperplasia. It also helps reduce the risk of acute urinary retention and the need for surgical intervention.
Form: capsules, soft gelatin
Active substance Dosage dutasteride 0.5 mg ATC: G04CB02
Manufacturer: WORLD MEDICINE ILAC SAN. VE TIC. A.S.
-
The drug is used to treat symptoms of moderate to severe benign prostatic hyperplasia. It also helps reduce the risk of acute urinary retention and the need for surgical intervention for this condition.
Form: capsules, soft gelatin
Active substance Dosage dutasteride 0.5 mg ATC: G04CB02
Manufacturer: StridePharma Science Limited
-
The drug is used to treat the symptoms of moderate to severe benign prostatic hyperplasia. It also helps to reduce the risk of acute urinary retention and the risk of surgical intervention.
Form: capsules, soft gelatin
Active substance Dosage dutasteride 0.5 mg ATC: G04CB02
Manufacturer: Oliv Helsker